Regeneron Pharmaceuticals, Inc. (REGN)

Regeneron Pharmaceuticals Revenue by Segment

Period Ending	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020
Collaboration	7.33B	6.97B	6.66B	6.32B	6.06B	5.82B	5.60B	5.39B
Collaboration Growth	21.02%	19.69%	18.93%	17.26%	10.08%	1.76%	4.99%	6.56%
Net Product	6.31B	6.64B	7.00B	7.28B	7.63B	7.48B	7.32B	7.17B
Net Product Growth	-17.30%	-11.24%	-4.40%	1.57%	7.79%	7.98%	5.43%	3.59%
Other	701.80M	643.20M	559.40M	480.00M	515.00M	548.10M	572.20M	537.00M
Other Growth	36.27%	17.35%	-2.24%	-10.61%	-3.94%	21.45%	44.06%	38.72%

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.